
DRL Q4 FY25 Results: PAT, EBITDA grow by one-fifth, beat Street estimates; drug maker declares dividend
Dr Reddy's Labs Q4 FY25 Earnings: Hyderabad-based drug maker Dr Reddy's Laboratories (DRL) on Friday reported a consolidated net profit of Rs 1,593.9 crore for the quarter ended March 31, an increase of 22 per cent over the corresponding period a …